Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
All content for BioTech Weekly is the property of Ernst Oberortner and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
📢 Industry Highlights in Biotech & Life Sciences 📢 From leadership changes to licensing deals and product launches, here's a roundup of recent developments shaping the future of healthcare innovation: Sources 🔗 Biocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug Development 🔗 Radiant Biotherapeutics Appoints Deborah Geraghty, Ph.D., as President and Chief Executive Officer 🔗 enGene Announces Board and Leadership Appointments to Supp...
BioTech Weekly
Links (for anyone who wants to go deeper): Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation https://bio.news/latest-news/breaking-barriers-to-a-cure-patient-perspectives-matter-in-type-1-diabetes-innovation/Medicenna – Updates MDNA11 Clinical Trial Results at ESMO-IO Congress 2025 https://www.biotech.ca/news/medicenna-therapeutics-corp-updates-mdna11-clinical-trial-results-at-the-esmo-io-congress-2025-further-bolstering-its-anti-tumor-activity-in-advanced...
